Antibacterial drug therapy. Focus on new drugs

The Veterinary Clinics of North America. Small Animal Practice
M G Papich

Abstract

This article will focus on the drugs for which there has been a recent or renewed interest in veterinary medicine. Some of these are new drugs that were recently introduced. Others discussed may be human-label drugs for which there has been recent interest in veterinary medicine because of the need for a more active drug or convenient regimen. For drugs such as the aminoglycosides included here, recent information has provided us with updated dosage guidelines.

References

Aug 21, 1992·Science·H C Neu
Feb 28, 1991·The New England Journal of Medicine·G A Jacoby, G L Archer
Jan 1, 1990·The Journal of Antimicrobial Chemotherapy·R M Shepard, F C Falkner
Aug 1, 1984·Antimicrobial Agents and Chemotherapy·H MatsuiA Tachibana
Feb 1, 1995·Journal of Veterinary Pharmacology and Therapeutics·R P HunterJ A Olson
Oct 1, 1994·The Journal of Antimicrobial Chemotherapy·J BatesD T Griffiths
Jun 1, 1994·The Journal of Antimicrobial Chemotherapy·D J GriggsL J Piddock
Jun 1, 1996·The Journal of Antimicrobial Chemotherapy·H LodeT Schaberg
Nov 1, 1996·The Journal of Small Animal Practice·E VilmànyiM Wanner
Jun 1, 1997·The Journal of Antimicrobial Chemotherapy·C D FreemanC H Nightingale
Jun 1, 1997·The Journal of Antimicrobial Chemotherapy·K E Brighty, T D Gootz

❮ Previous
Next ❯

Citations

Apr 6, 2004·The Veterinary Clinics of North America. Small Animal Practice·Daniel O Morris
Feb 28, 2001·The Veterinary Clinics of North America. Small Animal Practice·J D Olsen
Feb 23, 2007·Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians·James W CarpenterRobert P Hunter
Jan 8, 2008·Journal of the American Animal Hospital Association·April L PaulCarsten Bandt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Related Papers

Journal of the American Veterinary Medical Association
J S Reid
Deutsche medizinische Wochenschrift
H Hof, H Lode
Current Clinical Topics in Infectious Diseases
A W Urban, W A Craig
Boletín de la Asociación Médica de Puerto Rico
C H Ramírez-Ronda
© 2022 Meta ULC. All rights reserved